Skip to main content
Caplight Logo









52North

52North

Private
CambridgeHealthcare & Life Scienceshttps://52north.health/

Last Round

Grant

Dec 3, 2024

Total Funding Raised

$10.22M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

52North is a medical technology company that develops in-vitro diagnostic and digital solutions to transform patient journeys in urgent care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Defense Tech, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

point-of-care diagnosticsportable diagnostic deviceremote patient monitoringPOC testingdigital healthmedtechclinical decision supportat-home diagnosticsdefense technologydual-use technologyremote triagebiomarker measurementhealth IoTtelemedicineAI diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

52North Comparables

Compare 52North with similar companies based on industry and business-model similarity.

52North comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Entia
91%
Commure
73%
Soulbrain Holdings Co. Ltd
69%

52North Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 3, 2024
SeedDec 3, 2024
GrantNov 22, 2022
SeedApr 29, 2022

Key People

Founding team and executive leadership

Umaima Malik Ahmad

CEO & Co-Founder, Co-Founder

Founding Team

Joe Neale

Chief Technology Officer

Executive Team

52North Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 6, representing 23% of headcount.

  • Jul 26, 2026

    Monthly visitors increased 37% MoM.

52North Filings

Explore SEC and related filing metadata, where available.

52North filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 52North's valuation, stock price, and market status.

Is 52North a public or private company?

52North is a private company.

What is the current stock price of 52North?

52North is a private company with no public stock price. No recent secondary market data is available.

How much is 52North worth (valuation)?

Valuation information for 52North is not publicly available.

Can I buy 52North stock?

52North shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 52North's last funding round?

52North's most recent funding round was Series A on December 3, 2024.

Who are the main investors in 52North?

Key investors in 52North include Cambridge Enterprise, Meridian Health Ventures.

Will 52North IPO soon?

No public IPO plans have been announced for 52North.

How can I track 52North secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 52North's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range22
Year Founded2018
Last FundingDec 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?